2010
DOI: 10.1007/s00415-010-5626-0
|View full text |Cite
|
Sign up to set email alerts
|

Laryngospasm as preceding symptom of amyotrophic lateral sclerosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

2
0
0

Year Published

2016
2016
2022
2022

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 7 publications
2
0
0
Order By: Relevance
“…A few case reports describe laryngospasm as a rare initial or presenting symptom of ALS. 4,5 Estimates of its prevalence from studies of patients with motor neuron disease and physician surveys range from 2% to 19%, 6,7 numbers that are comparable to the 4% rate reported by Gotesman et al, and similar to rates reported in the otolaryngology literature on bulbar symptoms in ALS. 8,9 Importantly, laryngospasm can be very frightening for patients and their caregivers, a conclusion supported by the authors' finding of frequent anxiety in patients with laryngospasm.…”
supporting
confidence: 72%
See 1 more Smart Citation
“…A few case reports describe laryngospasm as a rare initial or presenting symptom of ALS. 4,5 Estimates of its prevalence from studies of patients with motor neuron disease and physician surveys range from 2% to 19%, 6,7 numbers that are comparable to the 4% rate reported by Gotesman et al, and similar to rates reported in the otolaryngology literature on bulbar symptoms in ALS. 8,9 Importantly, laryngospasm can be very frightening for patients and their caregivers, a conclusion supported by the authors' finding of frequent anxiety in patients with laryngospasm.…”
supporting
confidence: 72%
“…There are few estimates of the overall frequency of laryngospasm in ALS. A few case reports describe laryngospasm as a rare initial or presenting symptom of ALS 4,5 . Estimates of its prevalence from studies of patients with motor neuron disease and physician surveys range from 2% to 19%, 6,7 numbers that are comparable to the 4% rate reported by Gotesman et al, and similar to rates reported in the otolaryngology literature on bulbar symptoms in ALS 8,9 …”
Section: Epidemiology and Clinical Impactsupporting
confidence: 55%